Key insights
- Analyst upgrades and margin optimism have driven a sharp rally in Ichor Holdings (ICHR). Vertical integration and internal manufacturing are expected to boost gross margins. However, the stock's fair value is estimated at $46.86, slightly below the current price, suggesting it may be overvalued. The semiconductor demand cycle remains supportive, but the extent of future growth is being questioned.
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge.
Interest in Ichor Holdings (ICHR) has picked up after several analyst upgrades highlighted expectations for better gross margins, ongoing operational restructuring, and supportive semiconductor demand cycles, putting fresh attention on the stock’s risk reward trade off.
See our latest analysis for Ichor Holdings.
The recent 11.81% 1 day share price return to US$47.62 caps a sharp 185.15% 90 day share price return, while the 1 year total shareholder return of 76.89% points to momentum that has been building rather than fading.
If you are watching how semiconductor suppliers are priced after analyst upgrades, it can also be useful to scan other AI linked names using our 34 AI infrastructure stocks
After such a sharp recent run and with the share price sitting only slightly below the average analyst target, the real question now is whether Ichor is still trading at a discount or if the market is already pricing in future growth?
Ichor's most followed valuation narrative points to a fair value of $46.86, sitting just below the latest close at $47.62, which puts recent analyst optimism into sharper context.
Vertical integration and ramping of internal manufacturing capacity for critical components are expected to significantly enhance gross margins once hiring and retention issues are resolved, and this operational inflection can drive meaningful net margin expansion as new products shift from qualification to scaled commercial production.
Read the complete narrative.
Curious what kind of revenue path and margin rebuild need to line up to support that fair value, and what profit multiple sits behind it? The full narrative spells out a detailed earnings trajectory, the assumed step up in profitability, and the valuation lens used to pull those moving parts back to a single present day number.
Result: Fair Value of $46.86 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, there is still meaningful risk if thin gross margins persist or if leadership changes disrupt the vertical integration and new product ramp that the current narrative leans on.
Find out about the key risks to this Ichor Holdings narrative.
While the most followed narrative frames Ichor as about 1.6% overvalued at a fair value of $46.86 versus the $47.62 share price, the market is telling a different story when you look at sales. On a P/S of 1.7x, Ichor sits well below peers at 7.4x and the fair ratio of 2.2x. This raises the question of whether earnings based models are being too harsh on a business priced like this.
See what the numbers say about this price — find out in our valuation breakdown.
Seeing both risks and rewards in this story, and wondering how it all nets out? Now is the time to review the details and form your own stance by looking through the 3 key rewards and 2 important warning signs
If Ichor has your attention, do not stop here. Use the same structured approach to uncover other opportunities that fit your return and risk preferences.
Spot potential mispricings by scanning 49 high quality undervalued stocks that combine quality fundamentals with attractive entry points.
Lock in income focused ideas by reviewing 15 dividend fortresses built around higher yielding companies.
Prioritise resilience by checking 76 resilient stocks with low risk scores that screen for companies with lower risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ICHR.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com